Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.56
-1.00 (-7.37%)
At close: Feb 27, 2026, 4:00 PM EST
13.00
+0.44 (3.50%)
After-hours: Feb 27, 2026, 5:36 PM EST

Phathom Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
175.1155.250.68--
Revenue Growth (YoY)
216.93%8001.47%---
Cost of Revenue
22.67.970.17--
Gross Profit
152.5147.280.52--
Selling, General & Admin
279.72290.66117.9310162.74
Research & Development
32.7834.0849.971.4472.34
Operating Expenses
312.5324.75167.83172.44135.08
Operating Income
-159.99-277.47-167.31-172.44-135.08
Interest Expense
-68.12-72.01-41.97-27.31-6.79
Interest & Investment Income
7.0415.167.882.130.04
Other Non Operating Income (Expenses)
-0.19-0.01-0.19-0.11-0.06
EBT Excluding Unusual Items
-221.25-334.33-201.59-197.72-141.88
Other Unusual Items
-----2
Pretax Income
-221.25-334.33-201.59-197.72-143.88
Net Income
-221.25-334.33-201.59-197.72-143.88
Net Income to Common
-221.25-334.33-201.59-197.72-143.88
Shares Outstanding (Basic)
7363513937
Shares Outstanding (Diluted)
7363513937
Shares Change (YoY)
15.42%23.18%31.11%5.72%11.36%
EPS (Basic)
-3.03-5.29-3.93-5.05-3.89
EPS (Diluted)
-3.03-5.29-3.93-5.05-3.89
Free Cash Flow
-167-266.91-139.21-147.57-148.79
Free Cash Flow Per Share
-2.29-4.22-2.71-3.77-4.02
Gross Margin
87.09%85.57%75.51%--
Operating Margin
-91.36%-502.18%-24532.55%--
Profit Margin
-126.35%-605.09%-29558.94%--
Free Cash Flow Margin
-95.37%-483.07%-20412.61%--
EBITDA
-159.35-276.67-166.74-171.82-134.56
EBITDA Margin
-91.00%----
D&A For EBITDA
0.630.80.580.620.52
EBIT
-159.99-277.47-167.31-172.44-135.08
EBIT Margin
-91.36%----
Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q